[CLINICAL ASPECTS AND THERAPY OF STEROID DIABETES].
D000305:Adrenal Cortex Hormones; D000310:Adrenal Gland Neoplasms; D000324:Adrenocorticotropic Hormone / Q000633:toxicity*; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D003348:Cortisone / Q000633:toxicity*; D003873:Dermatitis, Exfoliative; D012628:Dermatitis, Seborrheic; D003907:Dexamethasone; D003920:Diabetes Mellitus; D004485:Eczema; D006562:Herpes Zoster; D007328:Insulin; D008010:Lichen Planus; D008775:Methylprednisolone; D009450:Neurodermatitis; D010392:Pemphigus; D011239:Prednisolone; D011241:Prednisone / Q000009:adverse effects*; D011565:Psoriasis; D014116:Toxicology; D014221:Triamcinolone
D000305:Adrenal Cortex Hormones; D007328:Insulin; D014221:Triamcinolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D008775:Methylprednisolone
ADRENAL CORTEX HORMONES; ADRENAL GLAND NEOPLASMS; ARTHRITIS, RHEUMATOID; CORTICOTROPIN TOXICOLOGY; CORTISONE TOXICOLOGY; DEXAMETHASONE; DIABETES MELLITUS; ECZEMA; ERYTHRODERMA; HERPES ZOSTER; INSULIN; LICHEN PLANUS; METHYLPREDNISOLONE; NEURODERMATITIS; PEMPHIGUS; PREDNISOLONE; PREDNISONE TOXICOLOGY; PSORIASIS; SEBORRHEA; TOXICOLOGIC REPORT; TRIAMCINOLONE
KLINIK UND THERAPIE DES STEROIDDIABETES.